ENVERIC BIOSCIENCES, INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
ENVERIC BIOSCIENCES, INC. (ENVB) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-25.
Discontinued › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2020-03-25
- ENVERIC BIOSCIENCES, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2019 was $0.00.
- ENVERIC BIOSCIENCES, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2018 was $0.00.
- ENVERIC BIOSCIENCES, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2017 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-25 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-26 |
| 2017-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |